Severe pneumonia, respiratory syncytial virus infectious disease, human meta virus infectious diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The tracheal intubation patient who judged that I was hospitalized with a respiratory infectious disease (severe pneumonia, respiratory syncytial virus infectious disease, human meta virus infectious diseases), and a doctor needed abdominal position and the RTX (clearance mode) combination
Exclusion criteria
Exclusion criteria: The patient that an agreement was refused
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| [item evaluating abdominal position and an effect of RTX (clearance mode)] Data during an intubation period: I change the change of X-rays, blood test data, the instructions of the respiratory condition of it and compare the difference of data before and after the enforcement using mark order official approval of Wilcoxon belonging to in analysis during an intubation period [item evaluating safety] Presence of harm phenomena such as a flare of the skin with the practice, edema of the face, low blood pressure, tachycardia, the symptoms such as aspirations and accident extubation, tracheal intubation tube confinement by flexure and the secretion retention of the tracheal intubation tube, a tip status pulse route, an accident withdrawal or the flexure confinement of various drains | — |
Secondary
| Measure | Time frame |
|---|---|
| [item evaluating abdominal position and an effect of RTX (clearance mode)] 1)I investigate the days that I practiced from intubation day and the day when I introduced it 2)Basic data: Age of the patient, disease name, having underlying disease or not, the weight 3)Data before and after the enforcement of the patient: Vital signs, sedation depth (SBS), change of the amount of ventilation, change of change blood gas data of SpO2, EtCO2, 4)Data during an intubation period: I change the change of X-rays, blood test data, the instructions of the respiratory condition of it and compare the difference of data before and after the enforcement using mark order official approval of Wilcoxon belonging to in 3)analysis during an intubation period [item evaluating safety] 1)Presence of harm phenomena such as a flare of the skin with the practice, edema of the face, low blood pressure, tachycardia, the symptoms such as aspirations and accident extubation, tracheal intubation tube confinement by flexure and the secretion retention of the tracheal intubation tube, a tip status pulse route, an accident withdrawal or the flexure confinement of various drains | — |
Countries
Japan
Contacts
Saitama Medical Center PICU